Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

PRA Health Sciences, Inc. (PRAH)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Sep-30-20Jun-05-20Mar-31-20Dec-31-19Sep-30-19Jun-30-19Jun-05-19
   10-K10-Q8-K10-Q10-K10-Q10-Q8-K
Cash flows from operating activities:          
    Net income   206.7 239.5243.1198.4158.3 
    Adjustments to reconcile net income to net cash from operating activities:          
        Depreciation and amortization expense   95.0 119.6114.985.0112.6 
        Amortization of debt issuance costs and discount   1.3 1.81.81.41.9 
        Amortization of terminated interest rate swaps   7.7 6.56.55.06.8 
        Stock-based compensation expense   50.2 52.045.829.235.6 
        Unrealized foreign currency losses (gains)   13.9 -3.3-6.5-19.3-0.5 
        Change in fair value of acquisition-related contingent consideration   -43.9 0.6    
        Deferred income taxes   -17.6 -31.9-23.9-19.3-26.4 
        Other reconciling items   8.2 0.80.60.2-0.1 
        Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:          
            Prepaid expenses and other assets      -13.7   
            Income taxes      -31.0   
            Payment of acquisition-related contingent consideration       -118.3  
                Net cash provided by operating activities   428.8 273.1253.6243.0237.8 
   
Cash flows from investing activities:          
    Purchase of fixed assets   -88.6 -75.9-74.3-56.0-70.2 
    Proceeds from the sale of fixed assets   0.1 0.1  0.1 
    Cash (paid) received for interest on interest rate swap   -7.6 -0.50.70.71.3 
    Acquisition of Care Innovations, Inc., net of cash acquired     -159.1    
        Net cash used in investing activities   -213.2 -235.4-73.2-54.9-68.2 
   
Cash flows from financing activities:          
    Proceeds from issuance of long-term debt      1,300.0300.0  
    Repayment of long-term debt      -1,216.5   
    Borrowings on line of credit   393.8 333.8233.8 40.0 
    Repayments of line of credit   -215.0 -200.0-145.0 -40.0 
    Payment for debt issuance costs   -5.5 -5.0-4.5   
    Acquisition of noncontrolling interest       -4.1  
    Proceeds from stock issued under employee stock purchase plan and stock option exercises   48.3 38.345.837.943.9 
    Taxes paid related to net shares settlement of equity awards      -0.1   
    Repurchase and retirement of common stock       -300.0  
        Net cash provided by (used in) financing activities   -75.7 -59.9-90.7-97.1-150.7 
Effects of foreign exchange changes on cash, cash equivalents, and restricted cash   -7.2 -4.51.9-1.7-0.1 
    Change in cash, cash equivalents, and restricted cash   69.0 -26.891.689.318.7 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy